Literature DB >> 26788383

Chromobacterium violaceum Isolated from a Wound Sepsis: A Case Study from Nepal.

Shamshul Ansari1, Pramod Paudel2, Kishor Gautam2, Sony Shrestha1, Sangita Thapa1, Rajendra Gautam1.   

Abstract

Chromobacterium violaceum is a facultative anaerobic, Gram-negative rod, prevalent in tropical and subtropical regions. It enters through the skin injury and is capable of causing severe systemic infections leading to septic shock and multiorgan failure. It has been reported by few authors across the world but this is probably the first case of Chromobacterium violaceum isolated from wound sepsis from Nepal. In this study, a pus sample from the infection of a prick injury in the left middle finger was collected from the patient admitted to the intensive care unit. Bacteriological investigations of the pus sample revealed the causative organism to be Chromobacterium violaceum. This case study indicates that Chromobacterium violaceum can act as a potential cause of wound sepsis that may lead to the septic shock and if not treated timely, the mortality rate can be high as was in this study. Although this organism is very rare, the infection caused requires prompt treatment to minimize the mortality rate. Therefore, we recommend the timely diagnosis and antimicrobial therapy of this infection to combat the consequences led.

Entities:  

Year:  2015        PMID: 26788383      PMCID: PMC4695652          DOI: 10.1155/2015/181946

Source DB:  PubMed          Journal:  Case Rep Infect Dis


1. Introduction

Chromobacterium violaceum is a Gram-negative, rod-shaped, motile, and facultative anaerobic bacterium that gives positive catalase and oxidase reaction. It grows readily on different bacteriological culture media including nutrient agar (NA), blood agar (BA), chocolate agar (CA), and Muller-Hinton agar (MHA) at 35–37°C [1, 2]. Chromobacterium violaceum can be isolated from water and soil in tropical and subtropical regions [3]. The organism rarely infects humans; yet, occasionally, the organism can establish a severe systemic infection by entering the bloodstream via an open wound [4]. In most of the cases the organism enters through the breaching of skin, following contamination of soil or water. The effects range from cutaneous lesion to severe sepsis and septic shock progressing rapidly to the death due to the multiorgan failure [5, 6]. We have reported a case of wound sepsis and septic shock caused by Chromobacterium violaceum at Chitwan Medical College Teaching Hospital (CMCTH), Bharatpur, Chitwan, Nepal. Probably this is the first reported case of Chromobacterium violaceum from Nepal.

2. Case Presentation

A 45-year-old male came to the emergency service of Chitwan Medical College Teaching Hospital (CMCTH), a 600-bed referral hospital of central Nepal, at midnight (11:40 pm) with clinical presentation of fever, burning sensation over epigastric region, and difficulty in breathing for two days. There was no nausea and vomiting reported together with normal bowel and bladder. History of patient revealed prick injury in left middle finger by unknown foreign body seven days back. On examination the patient had blood pressure of 100/70 mmHg, pulse rate of 100 beats per minute, and respiratory rate of 24 breaths per minute and the patient was anxious. The close observation of middle finger enabled prick injury, swollen and tense, extension to middle and proximal phalynx, collection of pus, peeling of skin, sloughing off, presence of sinuses, and discharge of pus material. The patient was provisionally diagnosed as a case of wound sepsis with septic shock together with acute kidney injury (previously called renal failure). The patient underwent pus drainage and pus investigation for bacteriological profile (culture and antibiotic sensitivity result) and surgical consultation. The patient was admitted to intensive care unit (ICU) and after 2 hours the blood pressure was remarkably decreased and central venous pressure (CVP) line inserted, and inotropic support (noradrenaline) was started. The antimicrobial regime of piperacillin/tazobactam, flucloxacillin, and metronidazole was immediately started together with IV fluid (6 pints of dextrose normal saline over 24 hours), pantoprazole, and hydrocortisone. The collected pus sample was subjected to bacteriological investigations (Gram's staining, culture, and sensitivity testing). First, the pus sample was inoculated on MacConkey agar (MA), blood agar (BA), and chocolate agar (CA) and then Gram's staining was performed. All the inoculated plates were incubated at 37°C for overnight and, the next day, numerous growths of dark violet colonies with no hemolysis were observed. Subculture on Muller-Hinton agar (MHA) showed notable characteristic feature of nondiffusible, dark violet metallic pigment production. The growth was further carried out for biochemical testing for catalase, oxidase, triple sugar iron (TSI) agar, sulphide indole motility (SIM), urea hydrolysis, citrate utilization, methyl red, and Voges-Proskauer and the results of biochemical tests were described in Table 1. We felt difficulty in interpreting the result of oxidase test because of the violet color of colonies. However, this difficulty was overcome by incubating the agar plate anaerobically and there was no or minimum pigment formation as pigment production is inhibited by anaerobic environment. After a few hours under aerobic conditions, the colonies turned violet again.
Table 1

Bacteriological investigations and their results.

Bacteriological parametersResults
Gram's stainPlenty of pus cells and presence of Gram-negative rods
Bacterial growth on MA, BA, and CARound, smooth, convex, butyrous, medium size, dark violet colonies, nonlactose fermenting, nonhemolytic, notable production of nondiffusible, dark violet metallic pigment (violacein) in MHA
Triple sugar iron (TSI) agar
 Acid production in slantNegative
 Acid production in buttPositive
 Hydrogen sulphide productionNegative
 Gas productionNegative
 Glucose fermentationPositive
 Lactose and/or sucrose fermentationNegative
 Alkali production in slantPositive
Sulphide indole motility (SIM)
 MotilityPositive
 Hydrogen sulphide productionNegative
 Indole productionNegative
Urea hydrolysis test Negative
Citrate utilization test Negative
Catalase testPositive
Oxidase testPositive
Methyl red testNegative
Voges-Proskauer testNegative
Antibiotic susceptibility testing was performed on dark violet colonies for a range of antimicrobials (amikacin, gentamicin, ceftriaxone, ciprofloxacin, cotrimoxazole, piperacillin-tazobactam, meropenem, and amoxicillin-clavulanic acid) on MHA and the result of susceptibility test was interpreted according to the CLSI guidelines for non-Enterobacteriaceae Gram-negative bacteria [7]. On admission, the hematological investigations showed a decreased total leukocyte count with low hemoglobin (Table 2). The blood chemistry investigations also showed remarkable results except for random blood sugar concentration of 114.0 mg/dL (reference range 70–140 mg/dL) (Table 3). The presence of albumin in urine routine examination revealed the renal dysfunction whereas arterial blood gas disclosed severe metabolic acidosis. The electrocardiogram (ECG) of patient revealed the sinus tachycardia and chest X-ray showed infiltrates in bilateral middle and lower zone.
Table 2

Hematological investigations and their results.

ParametersResultsReference range
Total leukocyte count2,900/μL4,000–11,000/μL
Differential leukocyte count
 Neutrophils88%40–70%
 Lymphocytes10%20–40%
 Monocytes01%2–10%
 Eosinophils01%2–6%
 Basophils000-1%
Platelets count2,15,000/μL1,50,000–4,00,000/μL
Hemoglobin (Hb)9.4 gm/dL12–18 gm/dL
Table 3

Blood chemistry investigations and their results.

ParametersResultsReference range
Random blood sugar 114.0 mg/dL70–140 mg/dL
Blood urea77.0 mg/dL15–45 mg/dL
Creatinine1.8 mg/dL0.4–1.4 mg/dL
Sodium127.0 mmol/L135–150 mmol/L
Potassium3.5 mmol/L3.5–5.5 mmol/L
SGPT537.0 IU/L<42 IU/L
SGOT830.0 IU/L<37 IU/L
ALP224.0 IU/L64–306 IU/L
Serum amylase18.0 IU/L25–115 IU/L
Serum lipase169.0 IU/L73–393 IU/L
Troponin-INegative
The patient was subjected to debridement of abscess, the sloughed off tissues and necrotic material were removed, and the wound was washed with Betadine and hydrogen peroxide and then with normal saline. Betadine packing and dressing were applied and advised for daily dressing. Despite these vital procedures, the patient's condition worsened and death was declared after 21 hours of arrival to the hospital because of septic shock with multiple organ failure. The results of bacteriological investigation were yet to come. The antibiotic sensitivity report revealed that the isolate was susceptible to all subjected antimicrobials. Based on the bacteriological findings the causative agent was identified as Chromobacterium violaceum.

3. Discussion

Human infections caused by Chromobacterium violaceum are uncommon as very few cases have been reported in scientific literatures [2, 5] and we could not find any published literature from Nepal. To the best of our knowledge, this is the first case of Chromobacterium violaceum reported from wound sepsis from Nepal. However, few cases have been published from India, Vietnam, Brazil, and Argentina [8-11]. Apart from the several useful compounds (for environmental detoxification, bioprospecting, pest control, and therapeutics) this bacterium can produce violacein, a pigment that displays cytotoxic and antibacterial activity [5, 12]. The violacein production is unique to Chromobacterium violaceum, differentiating the organism from other tropical, soil dwelling organisms [13]. The dominant route of infection for this pathogen is through exposure of injured skin to contaminated water or soil, with effects ranging from cutaneous lesions and visceral abscesses to severe sepsis, which progresses rapidly to death [6]. One report from United States [14] and one report from India [2] described fatality rate to be as high as 57% in each study. In our case study, probably the pricking injury and the entry of organism may be while working in the paddy field filled with stagnant water contaminated with this organism. The quick evolution of disease and the antibiotic treatment failure result in a mortality rate of over 60% [10]. In this case study too, the sepsis was reported which terminated in the death of patient after 21 hours of arrival to the hospital due to fast progression of fatal consequences of sepsis and septic shock.

4. Conclusions

Our case report reinforces the quick and timely treatment of infections caused by Chromobacterium violaceum. Although this organism is very rare, the consequences developed due to the infection of this organism can be highly fatal. Thus, from this case study we recommend rapid diagnosis and prompt treatment of infections caused by Chromobacterium violaceum.
  12 in total

1.  Chromobacterium violaceum septicaemia from north India.

Authors:  Pallab Ray; Jyoti Sharma; Rungmei S K Marak; S Singhi; Neelam Taneja; Raj Kumar Garg; Meera Sharma
Journal:  Indian J Med Res       Date:  2004-12       Impact factor: 2.375

Review 2.  Chromobacterium violaceum: a review of pharmacological and industiral perspectives.

Authors:  N Durán; C F Menck
Journal:  Crit Rev Microbiol       Date:  2001       Impact factor: 7.624

3.  Two cases of Chromobacterium violaceum infection after injury in a subtropical region.

Authors:  J Lee; J S Kim; C H Nahm; J W Choi; J Kim; S H Pai; K H Moon; K Lee; Y Chong
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum.

Authors:  P R August; T H Grossman; C Minor; M P Draper; I A MacNeil; J M Pemberton; K M Call; D Holt; M S Osburne
Journal:  J Mol Microbiol Biotechnol       Date:  2000-10

5.  Identification of Chromobacterium violaceum genes with potential biotechnological application in environmental detoxification.

Authors:  Marta S P Carepo; Juliana S Nina de Azevedo; Jorge I R Porto; Alexandra R Bentes-Sousa; Jacqueline da Silva Batista; Artur L C da Silva; Maria P C Schneider
Journal:  Genet Mol Res       Date:  2004-03-31

6.  First case report from Argentina of fatal septicemia caused by Chromobacterium violaceum.

Authors:  S C Kaufman; D Ceraso; A Schugurensky
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

7.  Chromobacterium violaceum in siblings, Brazil.

Authors:  Isadora Cristina de Siqueira; Juarez Dias; Hilda Ruf; Eduardo Antonio G Ramos; Elves Anderson Pires Maciel; Ana Rolim; Laura Labur; Luciana Vasconcelos; Célia Silvany
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

8.  Chromobacterium violaceum: A rare bacterium isolated from a wound over the scalp.

Authors:  M Ravish Kumar
Journal:  Int J Appl Basic Med Res       Date:  2012-01

9.  A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia.

Authors:  James I Campbell; Nguyen Phu Huong Lan; Phan Tu Qui; Le Thi Dung; Jeremy J Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2013-01-04       Impact factor: 3.090

10.  Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems.

Authors:  Cláudia I Lima-Bittencourt; Spartaco Astolfi-Filho; Edmar Chartone-Souza; Fabrício R Santos; Andréa M A Nascimento
Journal:  BMC Microbiol       Date:  2007-06-21       Impact factor: 3.605

View more
  7 in total

1.  Bacteremia caused by a rare pathogen - Chromobacterium violaceum: a case report from Nepal.

Authors:  Narayan Prasad Parajuli; Anjeela Bhetwal; Sumitra Ghimire; Anjila Maharjan; Shreena Shakya; Deepa Satyal; Roshan Pandit; Puspa Raj Khanal
Journal:  Int J Gen Med       Date:  2016-12-05

2.  Chromobacterium violaceum Pathogenicity: Updates and Insights from Genome Sequencing of Novel Chromobacterium Species.

Authors:  Juliana H Batista; José F da Silva Neto
Journal:  Front Microbiol       Date:  2017-11-10       Impact factor: 5.640

3.  Bacteremia and Urinary Tract Infection Caused by Chromobacterium violaceum: Case Reports from a Tertiary Care Hospital in Kathmandu, Nepal.

Authors:  Narayan Dutt Pant; Subhash Prasad Acharya; Raju Bhandari; Uday Narayan Yadav; Dil Bahadur Saru; Manisha Sharma
Journal:  Case Rep Med       Date:  2017-04-05

4.  Multiple Liver Abscesses with a Skin Pustule due to Chromobacterium violaceum.

Authors:  Naoki Matsuura; Megumi Miyoshi; Nana Doi; Saori Yagi; Etsuko Aradono; Takuroh Imamura; Rintaro Koga
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

5.  Fatal Infection Caused by Chromobacterium violaceum: A Case Report from a Tertiary Care Hospital in Bangladesh.

Authors:  Sadia Sharmin; Aflatun Akter Jahan; S M Mostofa Kamal; Protim Sarker
Journal:  Case Rep Infect Dis       Date:  2019-04-23

Review 6.  Chromobacterium violaceum: A Review of an Unexpected Scourge.

Authors:  Bachti Alisjahbana; Josephine Debora; Evan Susandi; Guntur Darmawan
Journal:  Int J Gen Med       Date:  2021-07-09

7.  Chromobacterium violaceum- induced sepsis and multiorgan dysfunction, resembling melioidosis in an elderly diabetic patient: A case report with review of literature.

Authors:  Sagar Khadanga; Tadepalli Karuna; Dharmendra Dugar; Shakti Prasad Satapathy
Journal:  J Lab Physicians       Date:  2017 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.